本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.10
+0.01000.92%
盘后1.100.00000.00%18:08 EDT
成交量:8.11万
成交额:8.90万
市值:1,413.84万
市盈率:-1.01
高:1.12
开:1.11
低:1.08
收:1.09
数据加载中...
2019/06/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/28

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/05/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

招股说明书

Registration statement for certain foreign private issuers
2019/05/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/03/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/20

SEC问询函

[Cover]Correspondence
2019/03/12

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers